Daiwa Securities Group Inc. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 193 filers reported holding SAGE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3
-25.0%
2390.0%0.00%
Q1 2024$4
-20.0%
2390.0%0.00%
Q4 2023$50.0%2390.0%0.00%
Q3 2023$5
-54.5%
2390.0%0.00%
Q2 2023$11
+10.0%
2390.0%0.00%
Q1 2023$10
+11.1%
2390.0%0.00%
Q4 2022$9
-99.9%
239
+8.6%
0.00%
Q3 2022$9,000
+28.6%
2200.0%0.00%
Q2 2022$7,000
+16.7%
220
+27.9%
0.00%
Q1 2022$6,000
-14.3%
1720.0%0.00%
Q4 2021$7,000
-22.2%
172
-14.4%
0.00%
Q3 2021$9,000
+28.6%
201
+73.3%
0.00%
Q2 2021$7,000
-22.2%
1160.0%0.00%
Q1 2021$9,000
+12.5%
116
+18.4%
0.00%
Q4 2020$8,000
-55.6%
98
-66.4%
0.00%
Q3 2020$18,000
+125.0%
2920.0%0.00%
Q2 2020$8,0000.0%2920.0%0.00%
Q1 2020$8,000
-97.0%
292
-92.2%
0.00%
-100.0%
Q4 2019$269,000
-43.7%
3,723
+9.3%
0.00%
-50.0%
Q3 2019$478,000
-29.9%
3,405
-8.6%
0.00%
-33.3%
Q2 2019$682,000
-0.1%
3,725
-13.2%
0.01%0.0%
Q1 2019$683,000
+2176.7%
4,291
+1284.2%
0.01%
Q4 2018$30,000
-6.2%
310
+34.8%
0.00%
Q3 2018$32,000
-11.1%
2300.0%0.00%
Q2 2018$36,000
-2.7%
2300.0%0.00%
Q1 2018$37,0002300.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 99,306$14,027,0005.76%
Casdin Capital, LLC 312,000$44,070,0005.36%
Palo Alto Investors LP 840,372$118,703,0004.80%
BB BIOTECH AG 1,071,373$151,331,0004.00%
TRV GP II, LLC 37,362$5,277,0003.10%
Eversept Partners, LP 43,621$6,161,4662.70%
RA Capital Management 350,933$49,569,0002.65%
Eventide Asset Management 494,000$69,778,0002.56%
OAK RIDGE INVESTMENTS LLC 241,099$34,055,0001.88%
SUFFOLK CAPITAL MANAGEMENT LLC 93,000$13,136,0001.87%
View complete list of SAGE THERAPEUTICS INC shareholders